Trade Dress, Multiple Columns Need Quick Resolution - CHPA
This article was originally published in The Tan Sheet
Issues of columns and trade dress "have lingered too long and a response from FDA is urgently needed," the Consumer Healthcare Products Association asserts in an Oct. 22 letter to the agency.
You may also be interested in...
FDA should establish a well-defined process for manufacturers to file for exemptions under the OTC labeling final rule, the Cosmetic, Toiletry & Fragrance Association maintains in comments filed with FDA's Division of OTC Drugs Dec. 13.
FDA/industry working group meeting scheduled for Nov. 1 postponed to allow more time to review product relabeling sample submissions. Due to other commitments, FDA "personnel will not permit a shortened review time of the materials," the agency says. The first available date to reschedule the OTC labeling meeting is Nov. 23 from 10 a.m. to noon
A two-year extension of the implementation deadlines for FDA's final rule on over-the-counter drug labeling is requested by the Consumer Healthcare Products Association in a citizen petition submitted to the agency Oct. 1.